IMV Inc IMVIF

RE:Public Relations

[qwerty22]

What this announcement does for me is really place the pre-existing data in the right context as a post-hoc analysis. What the company signalled might happen, and what would really have been significant, is the next trial being registrational. What this trial is is exploratory. It's looking at that pattern in the spiral trial they uncovered and trying to see if it's real and where it came from. This in many ways is like the shift the Ovarian program did from combo to mono. It means more rounds of financing before they get to a registrational trial. It's not so much a step forward as a step sideways.
Market that!

billybobmontana wrote: It's  good to see that the Merck relationship is moving forward, though the announcement requires reading between the lines.  Question today is to see with such news, does Fred and the board know how to create interest in the public markets.  This should be considered significant.....let's see if they know how to market the news.